Ann: Bubs Q4 FY24 Quarterly Activity and Cashflow Statement, page-61

What I love about bubs turnaround in the last 12months due to new ceo/management.

Here is a recap of the awesome Qtr4, FY24 revenues update.
—-
- $100.2M in revenues, beating analyst forecast of $80M and it1’s $40M more than the $60M revenues in FY23.

- Qtr 4 revenues is $30M, that is 50% more than qtr4 FY23.

-US quarterlmy revenues of $12.8m, up 8% on pcp (Q4 FY23: $11.8m) and 63%year-on-year growth (FY23: $29.9m)

- China quarterly gross revenues of $8.8m, up from $1.4m in Q4 FY23 and 17% year-on-year growth (FY23: $16.3m)

- Australia quarterly gross revenues of $5.4m, up 6% on pcp (Q4 FY23: $5.1m) and 18%year-on-year growth (FY23: $22.2m)

- Rest of world (ROW) quarterly gross revenues of $2.0m, up 43% on pcp (Q4 FY23:$1.4m) and 14% year-on-year growth (FY23: $5.3m.

US scan sales of $1M plus per week and China reset will get us $150M to $200M revenues by this time next year imo.

We now know why new ceo/management keeps telling us we will be cashflow positive in FY25. First quarter FY25 would be very nice.

Hang on to your precious shares everyone and don’t get tricked into panick selling like the last 2 days and give up your shares so cheaply.

They are accumulating and laughing right now imo.